title: Selenium improves cardiac function by attenuating the activation of NF-kappaB due to ischemia-reperfusion injury.
abstract: Although selenium, an essential trace element and a component of glutathione peroxidase, is known to protect the heart from ischemia-reperfusion (I/R)-induced injury, the mechanisms of this protection are not fully understood. For this purpose, isolated rat hearts were subjected to 30 min of global ischemia followed by 30 min of reperfusion; sodium selenite (25-1,000 nM) was added in the perfusion medium 10 min prior to ischemia, as well as during reperfusion. Selenium caused a dose-dependent improvement in cardiac performance and attenuated the decrease in the ratio of reduced glutathione to oxidized glutathione, as well as the increased level of malondialdehyde in I/R heart. Elevated ratios of nuclear factor-kappaB (NF-kappaB) in particulate and cytosolic fraction and of phosphorylated NF-kappaB and total NF-kappaB in I/R hearts were reduced by selenium. Cardiac dysfunction in hearts perfused with xanthine plus xanthine oxidase mixture, as well as hydrogen peroxide, or subjected to Ca2+ paradox was also attenuated by selenium. These data suggest that selenium protects the heart against I/R injury due to its action on the redox state and deactivation of NF-kappaB in I/R hearts.
authors.affiliation: Department of Biophysics, School of Medicine, Ankara University, Ankara, Turkey.
authors.forename: Belma
authors.initials: B
authors.lastname: Turan
authors.forename: Harjot K
authors.initials: HK
authors.lastname: Saini
authors.forename: Ming
authors.initials: M
authors.lastname: Zhang
authors.forename: Dashang
authors.initials: D
authors.lastname: Prajapati
authors.forename: Vijayan
authors.initials: V
authors.lastname: Elimban
authors.forename: Naranjan S
authors.initials: NS
authors.lastname: Dhalla
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D015153:Blotting, Western; D002118:Calcium / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005978:Glutathione / Q000378:metabolism; D006321:Heart / Q000187:drug effects* / Q000502:physiology*; D006352:Heart Ventricles / Q000473:pathology; D015227:Lipid Peroxidation; D008297:Male; D008315:Malondialdehyde / Q000494:pharmacology; D017202:Myocardial Ischemia; D009206:Myocardium / Q000473:pathology; D016328:NF-kappa B / Q000378:metabolism*; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D010766:Phosphorylation; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury; D012643:Selenium / Q000378:metabolism / Q000494:pharmacology*; D018036:Selenium Compounds / Q000494:pharmacology; D013997:Time Factors; D014969:Xanthine Oxidase / Q000378:metabolism
chemical_list: D000975:Antioxidants; D016328:NF-kappa B; D018036:Selenium Compounds; C037341:sodium selenide; D008315:Malondialdehyde; D014969:Xanthine Oxidase; D005978:Glutathione; D012643:Selenium; D002118:Calcium